Peter Svennilson

Peter Svennilson was the founder of Three Crowns Capital Bermuda Ltd., founded in 1996, where the title held was Managing Partner from 1996 to 2006.
Mr. Svennilson is the founder of The Column Group LLC, founded in 2007, holding the title of Managing Partner since 2011.
Current jobs include Independent Director at Carmot Therapeutics, Inc. since 2020, Director at Circle Pharma, Inc. since 2020, Director at Ribon Therapeutics, Inc. since 2017, Trustee at Institute for Advanced Study, and Managing Partner at TCG Labs-Soleil.
Former jobs include Chairman at Aragon Pharmaceuticals, Inc. from 2009 to 2013, Chairman at Seragon Pharmaceuticals, Inc. from 2013 to 2014, Associate Managing Director at Nomura International Plc, Director at Rosetta Inpharmatics LLC from 1996 to 2006, Associate Managing Director at European Investment Bank, Director at Tercica, Inc., Director at PTC Therapeutics, Inc. from 2012 to 2014, Director at ChemoCentryx, Inc., Independent Director at NGM Biopharmaceuticals, Inc. from 2008 to 2020, Director at SomaLogic Operating Co., Inc., Independent Director at Constellation Pharmaceuticals, Inc. from 2016 to 2019, Independent Director at Immune Design Corp.
from 2013 to 2018, Independent Director at Revolution Medicines, Inc. from 2020 to 2021, Independent Director at Gritstone bio, Inc. from 2015 to 2019, Independent Director at Oric Pharmaceuticals, Inc. from 2015 to 2021, and Independent Director at Rapt Therapeutics, Inc. from 2020 to 2021.
Education includes an MBA degree from Stockholm School of Economics, conferred in 1985.